Big Sioux Wealth Management’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.36M Buy
143,587
+5,560
+4% +$44.4K 0.65% 25
2026
Q2
$1.21M Buy
138,027
+13,073
+10% +$99K 0.71% 18
2026
Q1
$958K Buy
124,954
+48,338
+63% +$331K 0.62% 20
2025
Q4
$152K Buy
+76,616
New +$174K 0.1% 83

Other funds holding IBRX

Big Sioux Wealth Management's IBRX Position: Q3 2026 in Review

Big Sioux Wealth Management increased its ImmunityBio (IBRX) stake by 4% in Q3 2026, buying an estimated $44.4K and bringing the position to 143,587 shares worth $1.36M. The position accounts for 0.65% of the portfolio, ranked #25.

Big Sioux Wealth Management first reported a position in IBRX in Q4 2025 and has held it in 4 quarters since. 407 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • Big Sioux Wealth Management held 143,587 shares of ImmunityBio worth $1.36M as of Q3 2026.
  • Big Sioux Wealth Management bought 5,560 ImmunityBio shares in Q3 2026, an estimated $44.4K.
  • ImmunityBio made up 0.65% of Big Sioux Wealth Management's portfolio in Q3 2026, its #25 holding.
  • Big Sioux Wealth Management first reported a position in ImmunityBio in Q4 2025 and has held it in 4 quarters since.
  • 407 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on Big Sioux Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.